more questions than answerswhy was the stock not halted by the exchange and the company not asked to comment on the trading activity?
if the answer is that it was due to a US stock newsletter recommendation, i'm not sure that is good news - especially if the hype contained in the excerpts posted here are representative of the report. suggesting onc is the next microsoft or macdonalds at this stage may certainly add to the hype and excitement, and perhaps price, but it is anything but a realistic comparison to make at this point or a solid basis for a sustained increase in price.
i don't consider stock newsletter readers as paritularly informed buying - and i also think that a pp right around the corner is a distinct possibility - there has been no news on the glio delay now entering its 5th month and there have only been 6 prostate patients treated in the 1 year that trial has been going on.
with limited results like that, it is unlikely that they will see serious partner money anytime soon, and they are still burning cash at $500K/month.
they are likely running well below Brad's 12 month cash cushion, and will run dangerously low over the next few months, if the cash isn't replenished somehow, especially considering they want to start a third systemic trial.
depending on the volume, i think tomorrow may present a good selling opportunity.